Product Information

CABTREO 1.2%-0.15%-3.15% GEL is a brand product labeled by Bausch Health US LLC, priced at $18.2075 per GM under NDC 00187000625. Its NADAC has been published 68 times since Jun 19, 2024.

CABTREO 1.2%-0.15%-3.15% GEL

clindamycin phosphate/benzoyl peroxide/adapalene
$18.2075per GM

Strength

1.5; 31; 12 mg/g; mg/g; mg/g

NDC

00187000625

Classification

Brand

Dosage Form

GEL

Route

TOPICAL

Last Updated

9/17/2025

Approval Type

New Drug (NDA)

FDA Application

NDA216632

On Market Since

10/20/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade
Retinoid
Retinoids

Price Statistics

The NADAC for CABTREO 1.2%-0.15%-3.15% GEL has been published 68 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$18.2075 per GM
All-time high$18.2075 (Oct 1, 2025)
All-time low$18.1256 (Jun 19, 2024)
52-week high$18.2075
52-week low$18.1798
Median price$18.1713
Average price$18.1707
Largest weekly change+0.3% (Jul 17, 2024)
Weeks tracked68
Tracking sinceJun 19, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

+0.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the clindamycin phosphate/benzoyl peroxide/adapalene market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of CABTREO 1.2%-0.15%-3.15% GEL?

The current National Average Drug Acquisition Cost (NADAC) for CABTREO 1.2%-0.15%-3.15% GEL, manufactured by Bausch Health US LLC, is $18.2075 per GM (NDC 00187000625), effective Oct 1, 2025.

How has the price of CABTREO 1.2%-0.15%-3.15% GEL changed over time?

Over the history we have for it, the NADAC for CABTREO 1.2%-0.15%-3.15% GEL has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for CABTREO 1.2%-0.15%-3.15% GEL?

Since Jun 19, 2024, the NADAC for CABTREO 1.2%-0.15%-3.15% GEL has ranged from a low of $18.1256 (Jun 19, 2024) to a high of $18.2075 (Oct 1, 2025), with a median of $18.1713 per GM.

Are there cheaper alternatives to CABTREO 1.2%-0.15%-3.15% GEL?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CABTREO 1.2%-0.15%-3.15% GEL, so no direct lower-cost alternative is listed.

Who manufactures CABTREO 1.2%-0.15%-3.15% GEL?

CABTREO 1.2%-0.15%-3.15% GEL (NDC 00187000625) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.